Articles

1. Pushing Poorly Soluble APIs Into Development 11/6/2013

   The active pharmaceutical ingredients (APIs) screened and selected to be transformed into efficacious and safe medicines often require alternative, innovative strategies in order to facilitate this journey and enable new therapies to enter the market.

2. DSM's Route Scouting & Implementation of Synthetic Processes Is A Cost-effective Solution For Commercialization 3/28/2012
   DSM's cost-effective solution in route design and implementation of synthetic processes offers the capability to support emerging pharma companies with high potential and biotechs project and small molecule projects.
3. Brochure: RHOBUST® Downstream Processing Technology 2/22/2012
   Rhobust® technology is a downstream processing technology for the manufacturing of recombinant proteins and antibodies.
4. Brochure: XD® Technology: Improve Biopharmaceutical Production 2/22/2012
   DSM's XD® Technology has been developed to drive yield improvements in the production of biopharmaceuticals.
5. Brochure: Biologics Contract Manufacturing & Technology Solutions 1/30/2012

   DSM provides turn-key biologic manufacturing solutions, contract manufacturing for preclinical development, clinical trials or commercial supply and reduced cost, risk, and time to market.

6. Alkermes Contract Pharma Services 9/28/2011

   With Alkermes Contract Pharma Services, you have the opportunity to outsource your development, scale-up and manufacturing requirements to a trusted, experienced and dedicated expert in outsourcing services.

7. Five Year Trouble Free Manufacturing For Large Pharma Company 9/28/2011

   Alkermes, through the merger with Elan Drug Technologies, to become Alkermes plc, has been developing and manufacturing commercial scale solid oral dosage products for over 40 years.

8. Brochure: Custom Synthesis 12/6/2010

   PharmaZell draws upon a long history of successful custom synthesis projects, performed on a proprietary basis for pharmaceutical companies worldwide.

9. Brochure: Contract Manufacturing 8/6/2010

   Drug Substance and Advanced Intermediate development and manufacture to support clinical through commercial requirements.

10. Poster: CMC For 505(b)(2) Applications 4/7/2010
    The Chemistry, Manufacturing, and Control (CMC) Section (Modules 2 & 3 of the Common Technical Document [CTD]) of any application to the FDA will be the cornerstone for demonstrating the quality of any drug product. A clear document that complies with the ICH Harmonized Tripartite Guideline per the ICH Steering Committee Meeting (9 Nov 2000) is instrumental to that process. By Lynn Gold, PhD, Ken Phelps, Kathryn Wekselman, PhD, RN, and Karen Seta-Aust, PhD, Camargo Pharmaceutical Services, LLC